OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visit
December 04, 2023 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...
HEALWELL AI Completes Acquisition of ‘Pentavere’, a Leading Healthcare AI and Data Science Company
December 04, 2023 07:00 ET
|
HEALWELL AI Inc.
HEALWELL AI Completes Acquisition of ‘Pentavere’, a Leading Healthcare AI and Data Science Company
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
December 04, 2023 07:00 ET
|
TScan Therapeutics, Inc.
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T...
EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints
December 04, 2023 07:00 ET
|
EyePoint Pharmaceuticals, Inc.
– Both EYP-1901 cohorts demonstrated a statistically non-inferior change in BCVA versus aflibercept control with a numerical difference of only -0.3 and -0.4 letters, respectively for the 2 mg and 3...
Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS)
December 04, 2023 07:00 ET
|
Polaris Group
TAIPEI, Taiwan and SAN DIEGO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550), today announced that the first patient is successfully dosed in a pivotal Phase 3 trial that...
Antibody Library Technology Market to Reach US$ 246.5 Million at 4% CAGR by 2034, States Fact.MR
December 04, 2023 07:00 ET
|
FACT.MR
Rockville, Dec. 04, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global Antibody Library Technology Market is estimated at US$ 165.8...
Update on Debt Funding
December 04, 2023 07:00 ET
|
Vast Resources PLC
Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining 4 December 2023 Vast Resources plc(‘Vast’ or the ‘Company’) Update on Debt Funding Vast Resources plc, the AIM-listed mining...
Cielo Announces Shares for Debt Transaction and Provides Additional Updates
December 04, 2023 07:00 ET
|
Cielo Waste Solutions Corp.
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Cielo Waste Solutions...
Talisker Announces Completion of the Portal and Initiation of Decline Construction at the Mustang Mine, Bralorne Gold Project
December 04, 2023 07:00 ET
|
Talisker Resources Ltd.
TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce completion of construction of the Mustang Mine portal...
Helium Evolution Announces Spudding of Joint Well
December 04, 2023 07:00 ET
|
Helium Evolution Incorporated
CALGARY, Alberta, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in...